Security Investigation

iRhythm Technologies, Inc. (NasdaqGS: IRTC)

36 Days left to seek lead plaintiff status.

Company Name:iRhythm Technologies, Inc.
Stock Symbol:NasdaqGS: IRTC
Court:Northern District of California
Class Period Start:01/11/2022
Class Period End (inclusive):05/30/2023
Filing Deadline:04/08/2024

Contact a Lawyer Now

(877) 515-1850

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 8, 2024 to file lead plaintiff applications in a securities class action lawsuit against iRhythm Technologies, Inc. (NasdaqGS: IRTC).

iRhythm and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

On May 30, 2023, the Company disclosed the receipt of a Warning Letter from the FDA regarding “non-conformities to regulations for medical devices, including medical device reporting requirements, relating to the Company’s Zio AT System and medical device quality system requirements,” specifically addressing a series of deficiencies tied to the marketing and capabilities of the Zio AT device that potentially posed a known but undisclosed risk to patients, for example transmission limits of arrhythmia or heart irregularity events.

On this news, the price of iRhythm’s shares fell $7.41 per share, or 6.1%, from a closing price of $121.68 on May 30, 2023, to a closing price of $114.27 on May 31, 2023.

If you purchased shares of iRhythm and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or fill out the form on this page.

The case is Glazing Employers and Glaziers’ Union Local #27 Pension and Retirement Fund v. iRhythm Technologies, Inc., No. 24-cv-706.

Click here to read the first filed complaint.